Switch to: References

Add citations

You must login to add citations.
  1. Inventing Oncomice: making natural animal, research tool and invention cohere.Rosemary Robins - 2008 - Genomics, Society and Policy 4 (2):1-15.
    This paper examines how the oncomouse became a patentable invention. The oncomouse began life in the laboratory, where it was genetically modified for use as a research tool to assist with the study of human cancer. Its design, a product of genetic modification, made the oncomouse potentially patentable subject matter. The United States was the first jurisdiction to award the patent and several others followed. However, the question of animal patenting was most contentious in Europe and Canada. In this paper (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Do We Care About Synbiodiversity? Questions Arising from an Investigation into Whether There are GM Crops in the Svalbard Global Seed Vault.Fern Wickson - 2016 - Journal of Agricultural and Environmental Ethics 29 (5):787-811.
    The Svalbard Global Seed Vault provides a backup of seed collections from genebanks around the world. It’s unique character has made it iconic in the public imagination as a ‘Noah’s Ark’ for crop plants. Its remote location and strict controls on access have, however, also lent it an air of mystery, swirling with conspiracy theories. In this paper, I first clarify the aims of the Vault, the history of its development and the policies and practices of its current operation. Given (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • The Patenting of Biological Materials in the United States: A State of Policy Confusion.Luigi Palombi - 2015 - Perspectives on Science 23 (1):35-65.
    This paper discusses the genesis of human DNA patents and the legal confusion and ramifications that ensued. Beginning in the mid-1970s with policymakers and lawmakers in the United States, confronted with an economy impacted by an oil crisis, inflation, growing and persistent unemployment and the fledgling biotechnology industry, this paper tracks the development of the practice until its banning in the US Supreme Court in June 2013. The paper raises serious questions regarding the relevance of a patent system—a system that, (...)
    Download  
     
    Export citation  
     
    Bookmark